TargetMol

TargetMol is a biochemical service provider headquartered in Boston, MA, offering extensive screening libraries and inhibitors to customers globally. With a client base in 50+ countries, it has become one of the largest global research suppliers for compound libraries and small molecule compounds. The company diligently updates and offers over 200 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activators, natural products, peptides, antibodies, and novel life-science kits for laboratory and scientific use. In addition, TargetMol is developing its CADD lab, providing virtual screening services for customers interested in computer-aided drug design. Founded in 2015, TargetMol aims to leverage its fast and efficient global supply chain, professional procurement process, and timely products to save time and cost for customers while leading in biology research and early drug discovery. The company also prides itself on its experienced customer service and technical support teams with backgrounds in the life science and Pharm industry, striving to be a sincere and trustworthy partner to its clients. TargetMol operates in the biotechnology, healthcare, manufacturing, and pharmaceutical industries. It emphasizes that all its products are for Research Use Only and not for human or veterinary therapeutic use. Currently, there is no publicly disclosed information about the company's last investment or its investors. Overall, TargetMol offers a robust range of products and services to cater to the research needs of chemical and biological laboratory clients worldwide, positioning itself as a significant player in the global biochemical services market.